ABIONYX Pharma accelerates its development by launching a new biomanufacturing campaign based

May 24, 2023

Toulouse, France May 23, 2023 – ABIONYX Pharma accelerates its development by launching a new biomanufacturing campaign based on the recently announced robust innovative process supported by an equity-linked financing facility

DOWNLOAD Abionyx press release

ABIONYX Pharma accelerates its development by launching a new biomanufacturing campaign based

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE AN AGREEMENT LICENSE FOR THE MARKETING OF THERANEXUS TX01 IN THE TREATMENT OF TWO RARE NEUROLOGICAL DISEASES

Establishment of a renewable equity financing line of a maximum amount of €2 million to support the ramp-up of the Revin industrial site

Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG Royalties for USD 50 million

Links